The state of Mississippi currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies. These trials are conducted in various cities, including Jackson, Tupelo, Hattiesburg and Flowood.
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Recruiting
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Gender:
All
Ages:
40 years and above
Trial Updated:
06/04/2024
Locations: University of Mississippi Medical Center, Jackson, Mississippi
Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease